As previously published, MACC1 (32) and ADPRH (33) ABCG2 (34), and ANG (35) correlate with glioma cell proliferation, invasion, immune infiltration, drug efficacy, and worse prognosis in glioma patients. The gene discussed is ADPRH; the disease is central nervous system cancer.